Damora Therapeutics, Inc. Ordinary Shares

DMRANASDAQ • USD
23.31 USD
↗ 0.75 (3.31%)🟢LIVE (AS OF 01:45 PM EST)
🟢Market: OPEN

Damora Therapeutics, Inc. Ordinary Shares (DMRA) is currently trading at $23.31. Technical indicators currently signal "Strong Buy". Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, DMRA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 17, 2026.

Open?$22.54
High?$23.69
Low?$22.21
Prev. Close?$22.56
Volume?294.2K
Avg. Volume?483.1K
VWAP?$23.14
Rel. Volume?0.61x
Bid / Ask
Bid?$23.45 × 100
Ask?$26.92 × 100
Spread?$3.47
Midpoint?$25.19
Valuation & Ratios
Market Cap?1.4B
Shares Out?61.9M
Float?45.9M
Float %?74.4%
P/E Ratio?N/A
P/B Ratio?2.82
EPS?-$1.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Employees
7
Market Cap
1.4B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-29
Address
100 FIFTH AVENUE
WALTHAM, MA 02451
Phone: (781) 281-9020
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?10.21%High
Short Interest?4.7M
Days to Cover?10.7
Free Float45.9M
Avg Daily Volume439.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?14.80Strong
Quick Ratio?14.80Strong
Cash Ratio?9.74Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
59
2.82CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
9
-13.4%WEAK▾
ROA?
S&P
3
-12.5%WEAK▾
Cash Flow & Enterprise
FCF?$-59133000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day